Cargando…

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline

Unsuccessfully treated posttraumatic stress disorder (PTSD) is a serious and life-threatening disorder. Two medications, paroxetine hydrochloride and sertraline hydrochloride, are approved treatments for PTSD by the Food and Drug Administration (FDA). Analyses of pharmacotherapies for PTSD found onl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feduccia, Allison A., Jerome, Lisa, Yazar-Klosinski, Berra, Emerson, Amy, Mithoefer, Michael C., Doblin, Rick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6751381/ https://www.ncbi.nlm.nih.gov/pubmed/31572236 http://dx.doi.org/10.3389/fpsyt.2019.00650

Ejemplares similares

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
por: Jerome, Lisa, et al.
Publicado: (2020)

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
por: Mithoefer, Michael C., et al.
Publicado: (2019)

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy
por: Wagner, Mark T, et al.
Publicado: (2017)

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder
por: Singleton, S. Parker, et al.
Publicado: (2023)

Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder
por: Ponte, Linnae, et al.
Publicado: (2021)

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial
por: Monson, Candice M., et al.
Publicado: (2020)

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study
por: Wolfson, Philip E., et al.
Publicado: (2020)

Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Gorman, Ingmar, et al.
Publicado: (2020)

The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
por: Marseille, Elliot, et al.
Publicado: (2020)

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study
por: Danforth, Alicia L., et al.
Publicado: (2018)

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial
por: Ot’alora G, Marcela, et al.
Publicado: (2018)

Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy
por: Feduccia, Allison A., et al.
Publicado: (2020)

Potential Psychiatric Uses for MDMA
por: Yazar‐Klosinski, BB, et al.
Publicado: (2017)

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
por: Mithoefer, Michael C, et al.
Publicado: (2013)

MDMA-assisted therapy is associated with a reduction in chronic pain among people with post-traumatic stress disorder
por: Christie, Devon, et al.
Publicado: (2022)

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
por: Gasser, Peter, et al.
Publicado: (2014)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

Pilot study suggests DNA methylation of the glucocorticoid receptor gene (NR3C1) is associated with MDMA-assisted therapy treatment response for severe PTSD
por: Lewis, Candace R., et al.
Publicado: (2023)

Fully Validated, Multi-Kilogram cGMP Synthesis of MDMA
por: Nair, Jay B., et al.
Publicado: (2021)

Relational and Growth Outcomes Following Couples Therapy With MDMA for PTSD
por: Wagner, Anne C., et al.
Publicado: (2021)

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
por: Mitchell, Jennifer M., et al.
Publicado: (2023)

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
por: Mithoefer, Michael C, et al.
Publicado: (2011)

MDMA-assisted psychotherapy; Inclusion of transgender and gender diverse people in the frontiers of PTSD treatment trials
por: Stauffer, Christopher S., et al.
Publicado: (2022)

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
por: Mitchell, Jennifer M., et al.
Publicado: (2021)

Psychedelic-Assisted Psychotherapy After COVID-19: The Therapeutic Uses of Psilocybin and MDMA for Pandemic-Related Mental Health Problems
por: Argento, Elena, et al.
Publicado: (2021)

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
por: Jardim, Alvaro V., et al.
Publicado: (2020)

MDMA-assisted psychotherapy for the treatment of PTSD
por: Reiff, Collin M., et al.
Publicado: (2020)

Perceived key change phenomena of MDMA-assisted psychotherapy for the treatment of severe PTSD: an interpretative phenomenological analysis of clinical integration sessions
por: Godes, Macha, et al.
Publicado: (2023)

Three regulatory compliant test systems show no signs of MDMA-related genotoxicity
por: Cohen, Isaac Victor, et al.
Publicado: (2021)

A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?
por: Sanchez, Connie, et al.
Publicado: (2014)

A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy
por: Sottile, Robert J., et al.
Publicado: (2022)

Psychotherapy-supported MDMA treatment for PTSD
por: Krystal, John H., et al.
Publicado: (2021)

Reported Cases of Serotonin Syndrome in MDMA Users in FAERS Database
por: Makunts, Tigran, et al.
Publicado: (2022)

MDMA for the treatment of misophonia, a proposal
por: Webb, Jadon, et al.
Publicado: (2022)

Current Perspective on MDMA-Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Thal, Sascha B., et al.
Publicado: (2018)

Possible cross-sensitivity between sertraline and paroxetine in a panic disorder patient
por: Khairkar, Praveen H., et al.
Publicado: (2010)

Spectrophotometric Determination of the Antidepressants Sertraline and Paroxetine HCl using 2,4-Dinitrofluorobenzene
por: Walash, M. I., et al.
Publicado: (2010)

Sertraline, Paroxetine, and Chlorpromazine Are Rapidly Acting Anthelmintic Drugs Capable of Clinical Repurposing
por: Weeks, Janis C., et al.
Publicado: (2018)

The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial
por: Bonn-Miller, Marcel O., et al.
Publicado: (2021)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review
por: Inouye, Ann, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_33vl8lgadfqsg5g3bpeqj5ckv6